55 related articles for article (PubMed ID: 9021254)
1. Comparison of pathological alterations in ALS and a murine transgenic model: pathogenetic implications.
Dal Canto MC
Clin Neurosci; 1995-1996; 3(6):332-7. PubMed ID: 9021254
[TBL] [Abstract][Full Text] [Related]
2. Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease.
Tu PH; Gurney ME; Julien JP; Lee VM; Trojanowski JQ
Lab Invest; 1997 Apr; 76(4):441-56. PubMed ID: 9111507
[TBL] [Abstract][Full Text] [Related]
3. Midbrain dopaminergic neuronal degeneration in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Kostic V; Gurney ME; Deng HX; Siddique T; Epstein CJ; Przedborski S
Ann Neurol; 1997 Apr; 41(4):497-504. PubMed ID: 9124807
[TBL] [Abstract][Full Text] [Related]
4. Amyotrophic lateral sclerosis and Alzheimer disease. Lessons from model systems.
Price DL; Wong PC; Borchelt DR; Pardo CA; Thinakaran G; Doan AP; Lee MK; Martin LJ; Sisodia SS
Rev Neurol (Paris); 1997 Sep; 153(8-9):484-95. PubMed ID: 9683997
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic benefits of putrescine-modified catalase in a transgenic mouse model of familial amyotrophic lateral sclerosis.
Reinholz MM; Merkle CM; Poduslo JF
Exp Neurol; 1999 Sep; 159(1):204-16. PubMed ID: 10486188
[TBL] [Abstract][Full Text] [Related]
6. [Molecular mechanism of ALS and a possible gene therapy].
Abe K; Warita H
Rinsho Shinkeigaku; 1999 Jan; 39(1):68-9. PubMed ID: 10377808
[TBL] [Abstract][Full Text] [Related]
7. [Two siblings of familial amyotrophic lateral sclerosis with multisystemic degeneration characterized by mild involvement of the middle root zone of the posterior column, Clarke's nuclei and spinocerebellar tract].
Yoshida M; Okuda S; Murakami N; Hashizume Y; Sobue G
Rinsho Shinkeigaku; 1995 Jun; 35(6):589-99. PubMed ID: 8521632
[TBL] [Abstract][Full Text] [Related]
8. Phosphorylated Smad2/3 immunoreactivity in sporadic and familial amyotrophic lateral sclerosis and its mouse model.
Nakamura M; Ito H; Wate R; Nakano S; Hirano A; Kusaka H
Acta Neuropathol; 2008 Mar; 115(3):327-34. PubMed ID: 18210139
[TBL] [Abstract][Full Text] [Related]
9. Superoxide dismutase--applications and relevance to human diseases.
Noor R; Mittal S; Iqbal J
Med Sci Monit; 2002 Sep; 8(9):RA210-5. PubMed ID: 12218958
[TBL] [Abstract][Full Text] [Related]
10. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS).
Dal Canto MC; Gurney ME
Brain Res; 1995 Apr; 676(1):25-40. PubMed ID: 7796176
[TBL] [Abstract][Full Text] [Related]
11. Copper/zinc superoxide dismutase 1 and sporadic amyotrophic lateral sclerosis: analysis of 155 cases and identification of a novel insertion mutation.
Jackson M; Al-Chalabi A; Enayat ZE; Chioza B; Leigh PN; Morrison KE
Ann Neurol; 1997 Nov; 42(5):803-7. PubMed ID: 9392581
[TBL] [Abstract][Full Text] [Related]
12. Selective loss of alpha motoneurons innervating the medial gastrocnemius muscle in a mouse model of amyotrophic lateral sclerosis.
Mohajeri MH; Figlewicz DA; Bohn MC
Exp Neurol; 1998 Apr; 150(2):329-36. PubMed ID: 9527903
[TBL] [Abstract][Full Text] [Related]
13. Mitochondrial alterations in transgenic mice with an H46R mutant Cu/Zn superoxide dismutase gene.
Sasaki S; Aoki M; Nagai M; Kobayashi M; Itoyama Y
J Neuropathol Exp Neurol; 2009 Apr; 68(4):365-73. PubMed ID: 19287315
[TBL] [Abstract][Full Text] [Related]
14. Highlight Commentary on "Redox proteomics analysis of oxidatively modified proteins in G93A-SOD1 transgenic mice--a model of familial amyotrophic lateral sclerosis".
Calabrese V
Free Radic Biol Med; 2007 Jul; 43(2):160-2. PubMed ID: 17603925
[TBL] [Abstract][Full Text] [Related]
15. Mutation of superoxide dismutase elevates reactive species: comparison of nitration and oxidation of proteins in different brain regions of transgenic mice with amyotrophic lateral sclerosis.
Liu D; Bao F; Wen J; Liu J
Neuroscience; 2007 Apr; 146(1):255-64. PubMed ID: 17368952
[TBL] [Abstract][Full Text] [Related]
16. Degeneration of the substantia nigra in familial amyotrophic lateral sclerosis.
Wolf HK; Crain BJ; Siddique T
Clin Neuropathol; 1991; 10(6):291-6. PubMed ID: 1764852
[TBL] [Abstract][Full Text] [Related]
17. Enhanced superoxide dismutase-2 immunoreactivity of astrocytes and occasional neurons in amyotrophic lateral sclerosis.
Blaauwgeers HG; Vianney de Jong JM; Verspaget HW; van den Berg FM; Troost D
J Neurol Sci; 1996 Sep; 140(1-2):21-9. PubMed ID: 8866423
[TBL] [Abstract][Full Text] [Related]
18. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis.
Dal Canto MC; Gurney ME
Am J Pathol; 1994 Dec; 145(6):1271-9. PubMed ID: 7992831
[TBL] [Abstract][Full Text] [Related]
19. Neuropathology of amyotrophic lateral sclerosis: new perspectives on an old disease.
Chou SM
J Formos Med Assoc; 1997 Jul; 96(7):488-98. PubMed ID: 9262052
[TBL] [Abstract][Full Text] [Related]
20. Neurofilaments and motor neuron disease.
Julien JP
Trends Cell Biol; 1997 Jun; 7(6):243-9. PubMed ID: 17708953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
